Environmental change challenges decision-making during post-market environmental monitoring of transgenic crops

The ability to decide what kind of environmental changes observed during post-market environmental monitoring of genetically modified (GM) crops represent environmental harm is an essential part of most legal frameworks regulating the commercial release of GM crops into the environment. Among others, such decisions are necessary to initiate remedial measures or to sustain claims of redress linked to environmental liability. Given that consensus on criteria to evaluate ‘environmental harm’ has not yet been found, there are a number of challenges for risk managers when interpreting GM crop monitoring data for environmental decision-making. In the present paper, we argue that the challenges in decision-making have four main causes. The first three causes relate to scientific data collection and analysis, which have methodological limits. The forth cause concerns scientific data evaluation, which is controversial among the different stakeholders involved in the debate on potential impacts of GM crops on the environment. This results in controversy how the effects of GM crops should be valued and what constitutes environmental harm. This controversy may influence decision-making about triggering corrective actions by regulators. We analyse all four challenges and propose potential strategies for addressing them. We conclude that environmental monitoring has its limits in reducing uncertainties remaining from the environmental risk assessment prior to market approval. We argue that remaining uncertainties related to adverse environmental effects of GM crops would probably be assessed in a more efficient and rigorous way during pre-market risk assessment. Risk managers should acknowledge the limits of environmental monitoring programmes as a tool for decision-making.     

Toxicity and radio-protective properties of pyridazine derivatives

In experiments in irradiated (CBA X S57B1)F1 mice a study was made of toxicity and radioprotective efficiency of some pyridazine and pyridazine dione derivatives. Some of these substances were shown to have a moderate protective action when administered intraperitoneally. A correlation was revealed between the chemical structure and the radioprotective properties of the compounds.     

THE INACTIVATION OF TRYPSIN : III. SPONTANEOUS INACTIVATION.

1. The rate of inactivation of purified trypsin solutions approximates closely that demanded by the monomolecular formula. The more carefully the solution is purified the closer the agreement with the formula. 2. The products formed by the action of trypsin on proteins renders the trypsin more stable. Gelatin and glycine have no effect. 3. The rate of inactivation of trypsin solutions containing these products does not follow the course of a monomolecular reaction but becomes progressively slower than the predicted rate. 4. The protective action of these substances is much greater if they are added all at once at the beginning of the experiment than if they are added at intervals. These observations may be quantitatively accounted for by the hypothesis that a compound is formed between trypsin and the inhibiting substance which is stable as well as inactive, and that the rate of decomposition depends on the amount of uncombined trypsin present. 5. Trypsin is most stable at a pH of 5 and is rapidly destroyed in strongly acid or alkaline solution. 6. The protective effect of the inhibiting substances is small on the acid side of pH 5, increases from pH 5 to 7, and then remains approximately constant.     

Biochemical effects of chlorpyrifos and deltamethrin on altered antioxidative defense mechanisms and lipid peroxidation in rat liver

Pesticides such as organophosphorus and organochlorine compounds commonly used in agriculture for achieving better quality products are toxic substances and lead to generation of reactive oxygen species (ROS) which have harmful effects on human health. While pyrethroid pesticides are used in preference to organophosphates and organochlorines due to their high effectiveness, low toxicity to non-target organisms and easy biodegradability, they may also produce oxidative stress. Thus, we investigated the effects of chlorpyrifos (CP, an organophosphate) and deltamethrin (DM, a pyrethroid pesticide) treatments at low and high doses on lipid peroxidation (LPO) and antioxidant enzyme activities such as SOD, GSH-Px and CAT in rat liver following 16 weeks exposure. Antioxidative defence mechanisms and lipid peroxidation in rat liver tissues display different responses depending on different pesticide treatments and doses. Biochemical analysis showed that administrations of the chlorpyrifos and deltamethrin cause liver damage. In the present study, we observed that lipid peroxidation levels are higher at high doses than at low doses, but DM caused more pronounced increase than CP. Experimentally, we have also observed that oxidant-antioxidant balance is more affected by deltamethrin treatment than by chlorpyrifos.     

Respiratory Health – Exposure Measurements and Modeling in the Fragrance and Flavour Industry

Although the flavor and fragrance industry is about 150 years old, the use of synthetic materials started more than 100 years ago, and the awareness of the respiratory hazard presented by some flavoring substances emerged only recently. In 2001, the US National Institute of Occupational Safety and Health (NIOSH) identified for the first time inhalation exposure to flavoring substances in the workplace as a possible occupational hazard. As a consequence, manufacturers must comply with a variety of workplace safety requirements, and management has to ensure the improvement of health and safety of the employees exposed to hazardous volatile organic compounds. In this sensitive context, MANE opened its facilities to an intensive measuring campaign with the objective to better estimate the real level of hazardous respiratory exposure of workers. In this study, exposure to 27 hazardous volatile substances were measured during several types of handling operations (weighing-mixing, packaging, reconditioning-transferring), 430 measurement results were generated, and were exploited to propose an improved model derived from the well-known ECETOC-TRA model. The quantification of volatile substances in the working atmosphere involved three main steps: adsorption of the chemicals on a solid support, thermal desorption, followed by analysis by gas chromatography-mass spectrometry. Our approach was to examine experimental measures done in various manufacturing workplaces and to define correction factors to reflect more accurately working conditions and habits. Four correction factors were adjusted in the ECETOC-TRA to integrate important exposure variation factors: exposure duration, percentage of the substance in the composition, presence of collective protective equipment and wearing of personal protective equipment. Verification of the validity of the model is based on the comparison of the values obtained after adaptation of the ECETOC-TRA model, according to various exposure scenarios, with the experimental values measured under real conditions. After examination of the predicted results, 98% of the values obtained with the proposed new model were above the experimental values measured in real conditions. This must be compared with the results of the classical ECETOC-TRA system, which generates only 37% of overestimated values. As the values generated by the new model intended to help decision-makers of the industry to implement adapted protective action and information, and considering the high variability of the working environments, it was of the utmost importance to us not to underestimate the exposure level. The proposed correction factors have been designed to achieve this goal. We wish to propose the present method as an improved monitoring tool to improve respiratory health and safety in the flavor and fragrance manufacturing facilities.     

Evidence that free radical generation occurs during scorpion envenomation

Although it is well established that symptomatology, morbidity and death following scorpion envenomation are due to increases in neurotransmitter release secondary to toxins binding to voltage-sensitive sodium channels, the mechanism by which venom action is involved in damaging heart, liver, lungs and kidneys remains unclear. We hypothesized that scorpion toxins could induce the generation of high levels of free radicals responsible for membrane damage in organs targeted by venom action. We have investigated lipid peroxidation in different organs, through the evaluation of thiobarbituric acid reactive substances (TBARS), after experimental envenomation of rats by toxic fractions of Androctonus australis Hector venom. We have shown that scorpion toxins cause considerable lipid peroxidation in most vital organs. We also evaluated the protective effects of antioxidants in mice injected with lethal doses of toxins. Among the drugs tested, N-acetylcysteine (NAC) was effective in protecting the mice when injected prior to toxin application. However, the free radical scavenging properties of NAC seem less implicated in these protective effects than its ability to increase the fluidity of bronchial secretions. We therefore conclude that free radical generation only plays a minor role in the toxicity of scorpion venom.     

Introduction to the Food and Drug Administration (FDA) regulatory process

FDA oversight of medical devices, including in vitro diagnostic devices (IVDs or laboratory tests), in the United States was a direct result of the passage of the Medical Device Amendments of 1976. This law introduced a series of general controls for medical devices including registration and listing, requirements for production using good manufacturing practices, and requirements for post-market reporting of device failures. This produced for the first time a menu of laboratory tests on the market, a system to ensure these were produced consistently over time, and a mechanism for FDA to identify problems with device use and to work with companies to ensure corrective action. This law also introduced the requirement for premarket review of new versions of old devices and of fundamentally new medical devices.     

How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review

Background

Policymakers and regulators in the United States (US) and the European Union (EU) are weighing reforms to their medical device approval and post-market surveillance systems. Data may be available that identify strengths and weakness of the approaches to medical device regulation in these settings.

Methods and Findings

We performed a systematic review to find empirical studies evaluating medical device regulation in the US or EU. We searched Medline using two nested categories that included medical devices and glossary terms attributable to the US Food and Drug Administration and the EU, following PRISMA guidelines for systematic reviews. We supplemented this search with a review of the US Government Accountability Office online database for reports on US Food and Drug Administration device regulation, consultations with local experts in the field, manual reference mining of selected articles, and Google searches using the same key terms used in the Medline search. We found studies of premarket evaluation and timing (n = 9), studies of device recalls (n = 8), and surveys of device manufacturers (n = 3). These studies provide evidence of quality problems in pre-market submissions in the US, provide conflicting views of device safety based largely on recall data, and relay perceptions of some industry leaders from self-surveys.

Conclusions

Few studies have quantitatively assessed medical device regulation in either the US or EU. Existing studies of US and EU device approval and post-market evaluation performance suggest that policy reforms are necessary for both systems, including improving classification of devices in the US and promoting transparency and post-market oversight in the EU. Assessment of regulatory performance in both settings is limited by lack of data on post-approval safety outcomes. Changes to these device approval and post-marketing systems must be accompanied by ongoing research to ensure that there is better assessment of what works in either setting. Please see later in the article for the Editors'' Summary.     

Electrogenesis from an ATPase-ATP-sodium pseudo pump.

The short circuit current and the open circuit voltage responses of membranes to ATP, which have been attributed to membrane ATPase acting as a sodium pump, have been reproduced not only in a lipid membrane containing solubilized ATPase but also in membranes formed of the phospholipids contained in ATPase. The response is greatest with cardiolipin, but occurs with other acidic phospholipids. This observation of electrogenesis without hydrolysis is a surface phenomenon probably due to the alignment of ATP on the phospholipid by ion association at its interface with the water phase. The finding constitutes a precaution for interpreting studies of membrane Na-K-ATPase or for its incorporation into an artificial membrane. The substances necessary for electrogenesis are present at the mitochondrial membrane, and the particular orientation of the ATP on the phospholipids in vitro suggests a role for this ion association in the function of Na-K-ATPase.     

Electrogenesis from an ATPase-ATP-sodium pseudo pump

Summary The short circuit current and the open circuit voltage responses of membranes to ATP, which have been attributed to membrane ATPase acting as a sodium pump, have been reproduced not only in a lipid membrane containing solubilized ATPase but also in membranes formed of the phospholipids contained in ATPase. The response is greatest with cardiolipin, but occurs with other acidic phospholipids. This observation of electrogenesis without hydrolysis is a surface phenomenon probably due to the alignment of ATP on the phospholipid by ion association at its interface with the water phase. The finding constitutes a precaution for interpreting studies of membrane Na–K-ATPase or for its incorporation into an artificial membrane. The substances necessary for electrogenesis are present at the mitochondrial membrane, and the particular orientation of the ATP on the phospholipids in vitro suggests a role for this ion association in the function of Na–K-ATPase.     

DIAGNOSIS AND TREATMENT OF GOUTY ARTHRITIS

The characteristic phenomena of acute gouty arthritis are acute arthritis in a middle-aged male, associated with serum uric acid above 6 mg. per 100 cc. and a satisfactory response to colchicine. Roentgenographically observable changes do not occur early.In recent years uric acid metabolism has been studied by means of isotope techniques utilizing labeled substances. Uric acid is excreted in relatively constant amounts by humans and is little affected by variations in dietary intake, except for purine or nucleic acid substances. Persons with gout have a greater total amount of uric acid and a lower turnover than normal persons.In the treatment of acute attacks of gout colchicine is still the most practical single drug, even though its pharmacologic action remains unknown.Benemid (probenecid) is a powerful uricosuric agent of low toxicity which has been subjected to extensive clinical trial for three years. It causes inhibition of the resorption of urate from the glomerular filtrate; the site of action is believed to be the tubular cells. The author''s usual dose is 2 gm. a day. This has caused a lowering of the uric acid in the serum and an increase in the urinary output.     

Acetophenone protection against cisplatin-induced end-organ damage

Cisplatin is a widely used and efficacious chemotherapeutic agent for treating solid tumors, yet it causes systemic end-organ damage that is often irreversible and detrimental to quality of life. This includes severe sensorineural hearing loss, hepatotoxicity, and renal injury. Based on the hard-soft acid-base theory, we recently developed two acetophenone-derived, enol-based compounds that directly interfere with the side effects of cisplatin. We investigated organ-specific and generalized toxicity in order to define dose-dependent responses in rodents injected with cisplatin with or without the protective compounds. All metrics that were used as indicators of toxicity showed retention of baseline or control measurements when animals were pre-treated with acetophenones prior to cisplatin administration, while animals injected with no protective compounds showed expected elevations in toxicity measurements or depressions in measurements of organ function. These data support the further investigation of novel acetophenone compounds for the prevention of cisplatin-induced end-organ toxicity.     

Sesquiterpene Lactones: More Than Protective Plant Compounds With High Toxicity

Sesquiterpene lactones (STLs) constitute a large group of secondary metabolites that are widely distributed in several angiosperm plant families and a few bryophytes, including liverworts. These metabolites are particularly diversified in the family Asteraceae, in which more than 5,000 compounds have been reported so far. In addition to their pharmacological importance and potential therapeutic applications, most STLs display a wide range of protective activities in plants, including acting as anti-herbivory and antimicrobial substances or inhibiting growth of competing plants. These activities are mainly related to their characteristic α,β-unsaturated structural elements, which can participate in Michael-type additions with biological nucleophiles that contain sulfhydryl groups. Supporting the protective roles of STLs, they are mainly located in glandular trichomes of aerial parts because the highly nonspecific toxicity of such compounds necessitates compartmentalization to prevent autotoxicity. However, STLs have also been reported in other aerial and underground organs, where they are assumed to exhibit other biological activities. Recent studies have suggested that these metabolites not only display protective activities due to toxicity but also play key physiological roles in mediating rhizosphere communication among plants, soil microorganisms and plant parasites. STLs have been directly implicated in plant phototropism, resulting in differential growth of a plant organ due to auxin inhibition when accumulated in response to a light stimulus. This review therefore not only highlights the protective roles of STLs in producing plants but also explores the physiological roles of these metabolites, thus providing insights for new research approaches for understanding the roles of STLs in plants and their potential future applications.     

Use of aquatic macrophytes as a bioassay method to assess relative toxicity,uptake kinetics and accumulated forms of trace metals

Floating aquatic macrophytes such as the Lemnaceae have many attributes which commend their use in laboratory and field investigations to assess both the toxicity of substances and the quality of freshwater systems. As well as their more well known advantages of small size, relative structural simplicity, rapid growth and vegetative reproduction and genetically homogenous populations, they are also excellent accumulators of a number of metallic elements. This raises the possibility of the use of these aquatic macrophytes in water quality monitoring and also as laboratory bioassays for toxicity and uptake studies. Results are presented of a study of the comparative toxicity, uptake kinetics and accumulated forms of thallium and cadmium in the duckweed, Lemna minor and the role of this methodology in water quality monitoring and hazard evaluation are discussed.     

Motor behavior and brain enzymatic changes after acute lead intoxication on different strains of mice

Lead is a nonphysiological metal that has been implicated in toxic processes that affect several organ systems in humans and other animals. Although the brain generally has stronger protective mechanisms against toxic substances than other organs have, exposure to lead results in several neurophysiological and behavioral symptoms. The administration of a single injection (i.p.) of lead acetate in mice is a model of acute Pb2 + toxicity. In the present study, this model was used to explore the magnitude of the effect of different doses, time intervals and mice strains on several biobehavioral parameters. We investigated the effects of acute lead acetate administration on body and brain weight, brain lead acetate accumulation and specially, spontaneous locomotion and brain catalase activity. Lead acetate was injected i.p. in outbred (Swiss or CD1) and inbred (BALB/c, C57BL/J6 or DBA/2) mice at doses of 0, 50, 100, 150 or 200 mg/kg. At different time intervals following this acute treatment, several biochemical, physiological and behavioral responses were recorded. Results indicated that acute lead acetate has deleterious dose-dependent effects on brain and body weight. The effect on body weight in the present study was transient, although lead acetate was detected in neural tissues for several days after administration. Spontaneous locomotor activity only was reduced up until 24 hours. The effect of lead on body weight was strain-dependent, with Swiss mice showing greater resistance compared to the other strains. Total brain catalase activity in lead-pretreated Swiss mice showed a significant induction. This enzymatic upregulation could provide a protective mechanism for oxidative stress in these mice.     

The assessment of field trials in GMO research around the world and their possible integration in field trials for variety registration

Most regulations worldwide stipulate that a new genetically modified (GM) crop event has to be compared to its closest non-GM counterpart as a corner stone of the pre-market risk assessment. To this end the GM crop and its comparator should be grown in field trials for a phenotypic comparison as well as for subsequent detailed analysis of the composition of the two crop varieties. A more in-depth globally harmonised approach for the conduct of these field trials is lacking. Only a few countries have formulated detailed protocols for the set-up of GM field trials. In some countries, commercial non-GM reference varieties need to be included in a field study to compile reliable data that indicate the range of natural variation for the compounds tested at the specific location. Detailed analysis of pre-market assessment reports have so far not shown the added value of including these reference varieties in the field trials. In all cases where specific values were found to be outside of the range of the reference varieties, it proved possible to draw conclusions on the part of the pre-market risk assessment that relates to the compositional analysis, on the basis of already available compositional data. With the increasing quality of several databases on compositional data of a growing number of crop species, it seems unlikely that reference varieties will become more important on future occasions. It was furthermore investigated whether this part of the risk assessment can be related to field trial requirements for variety registration with the explicit intention of reducing the data burden on producers of new GM plant varieties. Field trials for variety registration so far include an assessment of phenotypic characteristics that do not cover safety aspects, with the exception of establishment of the glycoalkaloid content in potatoes in the Netherlands and Sweden. It may, however, under certain conditions be relatively easy to exchange data from compositional measurements between variety registration and GM testing procedures, thus laying a foundation for testing the feasibility of combining both pre-market assessment procedures in a single pre-market evaluation path.     

Effect of inducers of DT-diaphorase on the toxicity of 2-methyl- and 2-hydroxy-1,4-naphthoquinone to rats

It has previously been shown that rats pre-treated with butylated hydroxyanisole (BHA), a well-known inducer of the enzyme DT-diaphorase, are protected against the toxic effects of 2-methyl-1,4-naphthoquinone but are made more susceptible to the harmful action of 2-hydroxy-1,4-naphthoquinone. In the present experiments, the effects of BHA have been compared with those of other inducers of DT-diaphorase. Rats were dosed with BHA, butylated hydroxytoluene (BHT), ethoxyquin (EQ), dimethyl fumarate (DMF) or disulfiram (DIS) and then challenged with a toxic dose of the naphthoquinones. All the inducers protected against the haemolytic anaemia induced by 2-methyl-1,4-naphthoquinone in rats, with BHA, BHT and EQ being somewhat more effective than DMF and DIS. A similar order of activity was recorded in the relative ability of these substances to increase hepatic activities of DT-diaphorase, consistent with a role for this enzyme in facilitating conjugation and excretion of this naphthoquinone. In contrast, all the compounds increased the haemolytic activity of 2-hydroxy-1,4-naphthoquinone. DMF and DIS were significantly more effective in this regard than BHA, BHT and EQ. DMF and DIS also caused a much greater increase in levels of DT-diaphorase in the intestine, suggesting that 2-hydroxy-1,4-naphthoquinone is activated by this enzyme in the gut. BHA, BHT and EQ had no effect on the nephrotoxicity of 2-hydroxy-1,4-naphthoquinone, but the severity of the renal lesions was decreased in rats pre-treated with DMF and DIS. The results of the present experiments show that modulation of tissue levels of DT-diaphorase may not only alter the severity of naphthoquinone toxicity in vivo, but may also change the relative toxicity of these substances to different target organs.     

Correlation of the aquarium goldfish toxicities of some phenols,quinones, and other benzene derivatives with their inhibition of autooxidative reactions

Hydroquinone when added to the aquarium water was found to be about a hundred times more toxic than phenol, to goldfish (and to Daphnia magna), but is only about twice as toxic when injected into fish or mammals. Tertiarybutyl catechol shows a similar high toxicity in the aquarium, while the toxicity of catechol, resorcinol, and pyrogallol approaches more closely that of phenol. As the substances of high aquarium toxicity are known to inhibit many oxidative and polymerizing autocatalytic "chain reactions," rank correlations were tabulated between the recorded inhibitory potency of various substances in these processes, and their aquarium toxicity for goldfish. The correlation between aquarium fish toxicity and electric oxidation potential (P 0.09) is more than suggestive, and becomes still more so if explainable discrepancies are excluded. Antioxidant fat stabilizers show suggestive correlation with fish toxicity (0.20), and better with electric oxidation potential (0.10). The photographic reduction potential gives suggestive correlation with fish toxicity (0.20) and somewhat better with the oxidation potential (0.15). The gasoline induction period correlation is more than suggestive with the oxidation potential (0.099), but rather poor for fish toxicity (0.265). The rubber anti-aging potency gives only poor correlation (0.39) with fish toxicity. The reasons for these divergencies are not clear; they may perhaps be connected with the solvent properties of the substrate. As an example, Lea (p. 175) cites that 0.01 per cent of maleic acid prevents rancidity of fats, but is rendered ineffective by the presence of water. Taken by themselves, no one of the P values is entirely convincing of the relationships stressed in this paper. However, the consistent finding of relatively small values of P lends considerable weight to the hypothesis that these chemicals act in a related manner; and that the chemical activity of a substance may furnish useful suggestions of its biologic potency, perhaps more so than the chemical constitution as such. The aquarium toxicity, for goldfish is a convenient means of classifying the biologic potency.     

Synthesis and pharmacological profile of serofendic acids A and B

We present efficient syntheses of serofendic acids A and B (SA-A and SA-B), novel neuroprotective substances isolated from fetal calf serum. Biological and pharmacological evaluation showed that SA-A and SA-B have potent protective action against glutamate-induced neurotoxicity, but do not interact directly with glutamate receptors. A pharmacokinetic study showed that they have good oral bioavailability in rats. The results indicate that SA-A and SA-B are potential lead compounds for candidate drugs to treat various neurological disorders.